Search
HOME
Achondroplasia
Disease
Literature
Materials
VOXZOGO
Literature
Materials
CLN2
Disease
Literature
Materials
BRINEURA
Literature
Materials
Haemophilia
Disease
Literature
Materials
ROCTAVIAN
Literature
Materials
MPS
Disease
MPS IV
Literature
Materials
MPS VI
Literature
Materials
NAGLAZYME
Literature
Materials
VIMIZIM
Literature
Materials
PKU
Disease
Literature
Materials
KUVAN
Literature
Materials
PALYNZIQ
Literature
Materials
Corporate
Stationery
Materials
Head Office
Quarantine
Restricted
Order Tracking
Contact
Need help?
+44 1732 783600
Sign in
1
Need help?
+44 1732 783600
Order Tracking
Contact
1
Cart (1)
Schulz (2021) Guidelines for CLN2 Disease Patients
Quantity
Schulz (2021) Guidelines for CLN2 Disease Patients quantity
£
0.00
×
Sign in
Username or Email Address
Password
Remember Me
HOME
Achondroplasia
Disease
Literature
Materials
VOXZOGO
Literature
Materials
CLN2
Disease
Literature
Materials
BRINEURA
Literature
Materials
Haemophilia
Disease
Literature
Materials
ROCTAVIAN
Literature
Materials
MPS
Disease
MPS IV
Literature
Materials
MPS VI
Literature
Materials
NAGLAZYME
Literature
Materials
VIMIZIM
Literature
Materials
PKU
Disease
Literature
Materials
KUVAN
Literature
Materials
PALYNZIQ
Literature
Materials
Corporate
Stationery
Materials
Head Office
Quarantine
Restricted
Home
>
MPS
>
Disease
Disease
(4)
View cart
“Schulz (2021) Guidelines for CLN2 Disease Patients” has been added to your cart.
Showing all 4 results
Default
Popularity
Latest
Price: low to high
Price: high to low
Sort by
Default
Default
Popularity
Latest
Price: low to high
Price: high to low
12
24
36
48
Show
12
Show
12
Show
24
Show
36
Show
48
Quick view
Add to cart
MPS-UM-EN-VI-OCT 18
Archimed MPS DBS Kit
Quantity
Quantity
Add to cart
Quick view
Add to cart
EU/MPS/1214
MPS Diagnostic Tool Folder
Quantity
Quantity
Add to cart
Quick view
Add to cart
BIO/EU/13/012
MPS VI (Polish)
Quantity
Quantity
Add to cart
Quick view
Add to cart
CLN2016
Schulz (2021) Guidelines for CLN2 Disease Patients
Schulz (2021) Guidelines on the diagnosis, clinical assessment, treatment and management for CLN2 disease patients.
Quantity
Quantity
Add to cart
Back to Top
Product has been added to your cart
Close
